je.st
news
Tag: diseases
Diseases on the move because of climate change
2013-12-04 21:28:00| Climate Ark Climate Change & Global Warming Newsfeed
USA Today: Software engineer Andres Chavez is used to doing things quickly, efficiently and correctly. So he knew something was seriously wrong when, on a business trip in 2009, he was so confused he could barely sign a stack of paperwork. "I felt like I was living a quarter-second in the past," he says of the onset of Valley Fever, a disease caused by a soil fungus. It took months for his doctor to finally suggest that might be the cause of Chavez's episodes of "getting stupid," as his wife calls it. "He...
Tags: change
move
diseases
climate
EU Commits Funds to Fight Animal Diseases in 2014
2013-12-03 01:00:00| ThePigSite - Industry News
EU - Over €160 million has been committed by the EU to support eradication and monitoring programmes that aim to eliminate animal diseases and zoonoses and further strengthen the protection of human and animal health.
Tags: animal
funds
fight
diseases
Weekly Outlook: Is Any Progress Being Made on Control of Serious Pig Diseases?
2013-12-02 01:00:00| ThePigSite - Industry News
ANALYSIS - As with so many important questions in life, the answer is "yes" and "no". There is an international response to the spread of African Swine Fever and yet the disease is spreading at a rapid rate in Russia despite the authorities' best attempts to control it. Classical Swine Fever has recurred in South Korea after more than four years. Porcine Epidemic Diarrhoea in the US has led analysts to reduce the estimates for pork production there for 2014.
Tags: made
control
progress
serious
Merck Announces Presentation of Interim Data from Study of Investigational Combination of HCV Therapies MK-5172 and MK-8742 at the 2013 American Association for the Study of Liver Diseases (AASLD) Annual Meeting
2013-11-02 14:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Sustained virologic response at post-treatment follow-up week 12 (SVR 12) seen in 100 percent of patients to date in two of the three combination arms studied WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the presentation of interim data from the ongoing C-WORTHY Study, a Phase II clinical trial evaluating the efficacy and safety of an all-oral regimen combining once-daily MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor, with or without twice-daily ribavirin, administered for 12 weeks to treatment-nave, non-cirrhotic pat Language: English Contact: MerckMedia:Pamela Eisele, (908) 423-5042Sarra Herzog, (908) 423-6154orInvestor:Carol Ferguson, (908) 423-4465Justin Holko, (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
SOLIAIR - New Respiratory And Lung Diseases Drug Discovery Released
2013-10-30 05:07:22| drugdiscoveryonline News Articles
SOLIAIR is a blend of botanical extracts and a food supplement that contains a unique composition of ingredients, which has reported beneficial impact
Tags: drug
released
discovery
diseases
Sites : [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] next »